Q1 Earnings Forecast for Affimed Issued By Leerink Partnrs
Affimed (NASDAQ:AFMD – Free Report) – Leerink Partnrs upped their Q1 2025 earnings estimates for Affimed in a note issued to investors on Tuesday, May 13th. Leerink Partnrs analyst D. Graybosch now forecasts that the biopharmaceutical company will earn ($0.39) per share for the quarter, up from their prior estimate of ($0.59). Leerink Partnrs currently […]
Affimed (NASDAQ:AFMD – Free Report) – Leerink Partnrs upped their Q1 2025 earnings estimates for Affimed in a note issued to investors on Tuesday, May 13th. Leerink Partnrs analyst D. Graybosch now forecasts that the biopharmaceutical company will earn ($0.39) per share for the quarter, up from their prior estimate of ($0.59). Leerink Partnrs currently […]
